Venture Capital

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

With sales rising and key FDA milestones met, Australian biotech Immuron resets its strategy, seeking partners to fund its promising infectious disease pipeline.

A new partnership between Salience Labs and Tower Semiconductor aims to mass-produce optical switches, a critical technology for faster, greener AI data centers.

As global ESG rules become a complex web, Datamaran's new AI platform aims to help firms move from reactive compliance to proactive corporate strategy.

With a new CEO at the helm and a pivotal trial for its lead drug on the horizon, all eyes are on PureTech's upcoming investor conference presentation.

The diabetes tech firm secures major funding for innovation and acquisitions, using a savvy financial strategy to protect current shareholder value.

A new tech startup is launching an AI platform to replace high-pressure sales with transparent pricing, promising to cut homeowners' roof costs by up to 50%.

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

Pioneering clean beauty brand Indie Lee launches an affordable new line, Indie Lee Botanicals, exclusively at Whole Foods Market, making quality skincare accessible.

With $6.9M in total funding, the UMass spin-out is set to disrupt AR and AI markets with its durable, all-inorganic nano-imprinted optical components.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

The Raine Group hires Credit Suisse veteran Anthony Kontoleon, signaling a major push to dominate TMT advisory ahead of an anticipated tech boom.

With new high-protein flavors, Forager Project is betting on a unique cashew-based recipe to win over consumers disappointed by other dairy-free options.

As smugglers take to the sea in high-tech subs, companies like Jeffs' Brands are betting on AI-driven underwater security to turn the tide.

With 43% YoY growth, Cato Networks is outpacing the SASE market. A new acquisition and key hires signal a deep focus on securing the AI era.

Kenai Therapeutics hires a Novartis M&A veteran as CBO, signaling an aggressive strategy to advance its groundbreaking iPSC cell therapy for Parkinson's disease.

A bootstrapped AI platform just won an award previously held only by FanDuel and DraftKings. Discover how PlayerProps.ai is changing the game.